ELDEPRYL

Main information

  • Trade name:
  • ELDEPRYL 5 mg tablet
  • Dosage:
  • 5 mg
  • Pharmaceutical form:
  • tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ELDEPRYL 5 mg tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Selegiline
  • Product summary:
  • Suitability for use in older adult patients Selegilini hydrochloridum Suitable for older persons, with specific cautions. Serotonergic. Note the contraindications. Reduce the dose in even mild renal insufficiency. Significant adverse effects include depression, hallucinations, headache, dizziness, allergy, angina pectoris and musculoskeletal pain. Combined use with SSRIs and SNRIs, tricyclic and tetracyclic antidepressants involves a risk of serotonin syndrome; however, in practice this risk is low.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 8431
  • Authorization date:
  • 01-02-2008
  • Last update:
  • 26-07-2018